Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC373

Amivantamab

  • Status:
    Veitt
  • Application date:
    28.4.2022
  • Application published:
    15.5.2022
  • Grant published:
    15.2.2024
  • Max expiry date:
    9.12.2036
  • Medicine name:
    Rybrevant
  • Medicine for children:
    No

Timeline

Today
28.4.2022Application
15.5.2022Publication
15.2.2024Registration
9.12.2036Expires

Marketing license

  • IS authorization number:
    EU/1/21/1594/001
  • Date:
    30.12.2021
  • Foreign authorization number:
    EU/1/21/1594
  • Date:
    9.12.2021

Owner

  • Name:
    Janssen Biotech, Inc.
  • Address:
    800/850 Ridgeview Drive, Horsham, PA US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 09.02.2024

Upload documents